- South Korea plans to conduct clinical trials for a COVID-19 drug based on antibodies later this year, aiming to have the medicine ready next year.
- The country estimates that a vaccine won’t be ready until late 2021 at the earliest, or more likely sometime in 2022.
- Other countries have used plasma from survivors of the novel coronavirus disease to treat severe COVID-19 cases.
- Visit BGR’s homepage for more stories.
Doctors have been treating COVID-19 with a wide range of therapies, attempting to prevent complications and attend to symptoms. However, there are no specific drugs for the novel coronavirus and that explains why you keep hearing about cures that may work on some patients and fail on others. Medical professionals are running several studies to see which drugs have a chance of improving COVID-19 prognosis, but nothing can move too quickly in this regard. Vaccines will ultimately be the only way to prevent infection and hopefully eradicate the disease, but we’ll have to wait another 18 months to get them. Before that happens, South Korea might have a COVID-19 drug based on the only type of cure that works right now: Antibody treatment.
Today’s Top Deals
- Secret sale: Get a Fire TV Stick 4K at Amazon’s lowest price ever
- Amazon is blowing out Nest thermostats at the lowest prices of the year
- Today’s top deals: DIY coronavirus face masks, $22 true wireless earbuds, $6 Alexa smart plugs, Philips Hue sale, more
Trending Right Now:
- A bizarre new coronavirus symptom has been discovered
- Here’s the federal government’s plan for reopening the country, starting in May
- A simple new treatment is saving coronavirus patients’ lives
Crucial coronavirus antibody drug could be ready sooner than expected originally appeared on BGR.com on Thu, 16 Apr 2020 at 19:07:15 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report